| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-138 |
Sentence |
denotes |
[Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis]. |
| T1 |
0-138 |
Sentence |
denotes |
[Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis]. |
| TextSentencer_T2 |
139-306 |
Sentence |
denotes |
We report a 43-year-old female who developed pulmonary arterial hypertension (PAH) during intensive immunosuppressive therapy for systematic lupus erythematosus (SLE). |
| T2 |
139-306 |
Sentence |
denotes |
We report a 43-year-old female who developed pulmonary arterial hypertension (PAH) during intensive immunosuppressive therapy for systematic lupus erythematosus (SLE). |
| TextSentencer_T3 |
307-442 |
Sentence |
denotes |
She was diagnosed as SLE at the age of 32 years based on serological and hematological abnormalities, oral ulcers, and facial erythema. |
| T3 |
307-442 |
Sentence |
denotes |
She was diagnosed as SLE at the age of 32 years based on serological and hematological abnormalities, oral ulcers, and facial erythema. |
| TextSentencer_T4 |
443-605 |
Sentence |
denotes |
She experienced frequent flare-ups of disseminated discoid lupus between the ages of 33 and 36 years and developed immune thrombocytopenia at the age of 39 years. |
| T4 |
443-605 |
Sentence |
denotes |
She experienced frequent flare-ups of disseminated discoid lupus between the ages of 33 and 36 years and developed immune thrombocytopenia at the age of 39 years. |
| TextSentencer_T5 |
606-771 |
Sentence |
denotes |
In 2007 when she was 43 years old, she developed lupus nephritis (LN) with elevated serum anti-double stranded DNA antibodies and urine protein of less than 1 g/day. |
| T5 |
606-771 |
Sentence |
denotes |
In 2007 when she was 43 years old, she developed lupus nephritis (LN) with elevated serum anti-double stranded DNA antibodies and urine protein of less than 1 g/day. |
| TextSentencer_T6 |
772-894 |
Sentence |
denotes |
Combination therapy for the LN with 35 mg/day prednisolone and intravenous cyclophosphamide (IVCY) led to renal remission. |
| T6 |
772-894 |
Sentence |
denotes |
Combination therapy for the LN with 35 mg/day prednisolone and intravenous cyclophosphamide (IVCY) led to renal remission. |
| TextSentencer_T7 |
895-972 |
Sentence |
denotes |
After the seventh monthly session of IVCY, she developed dyspnea on exertion. |
| T7 |
895-972 |
Sentence |
denotes |
After the seventh monthly session of IVCY, she developed dyspnea on exertion. |
| TextSentencer_T8 |
973-1305 |
Sentence |
denotes |
PAH was diagnosed based on enlarged main pulmonary arteries on the chest x-ray, right ventricular outflow and a peak tricuspid regurgitant pressure gradient exceeding 45 mmHg on echocardiography, an elevated plasma brain natriuretic peptide (BNP) level of 260 pg/ml, the exclusion of pulmonary thromboembolism, and no lung fibrosis. |
| T8 |
973-1305 |
Sentence |
denotes |
PAH was diagnosed based on enlarged main pulmonary arteries on the chest x-ray, right ventricular outflow and a peak tricuspid regurgitant pressure gradient exceeding 45 mmHg on echocardiography, an elevated plasma brain natriuretic peptide (BNP) level of 260 pg/ml, the exclusion of pulmonary thromboembolism, and no lung fibrosis. |
| TextSentencer_T9 |
1306-1353 |
Sentence |
denotes |
The PAH was treated successfully with bosentan. |
| T9 |
1306-1353 |
Sentence |
denotes |
The PAH was treated successfully with bosentan. |
| TextSentencer_T10 |
1354-1450 |
Sentence |
denotes |
At present the tricuspid regurgitation has disappeared, and the plasma BNP level has normalized. |
| T10 |
1354-1450 |
Sentence |
denotes |
At present the tricuspid regurgitation has disappeared, and the plasma BNP level has normalized. |